Save Search

Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document

3 March 2011

* 230  MR HAASE: To ask the Minister for Infrastructure and Transport—

(1) Will funds be available for Carnarvon in WA under the Natural Disaster Resilience Program (NDRP); if so, what sum.

(2) What funds under the NDRP (a) are still available, and (b) r emain unallocated, for WA.

(3) Given the flood levy construction program in Carnarvon remains incomplete, will funds from the NDRP be available for levy bank construction in Carnarvon; if so, what sum.

(4) What maximum percentage of levy bank construction costs in Carnarvon will be met by the NDRP.

* 231  MR OAKESHOTT: To ask the Treasurer—By what date will the Government provide its full response to the ‘Henry Tax Review’ (Australia’s Future Tax System Review Panel, Australia's Future Tax System Review , 2 May 2010).

* 232  MR OAKESHOTT: To ask the Treasurer—Following reports that the family of Colonel Muammar Al-Qaddafi has been a regular visitor to Australia and invested widely within Australia, can the Treasurer outline what steps are being taken to determine the extent of these investments and their legitimacy.

* 233  MR FITZGIBBON: To ask the Minister for Health and Ageing—

(1) What total sum of funding was provided to the Hunter Urban Division of General Practice (GP Access) in (a) 2007-08, (b) 2008-09, (c) 2009-10, and (d) 2010-11.

(2) What proportion of funding in each year in part (1) was for the operation of the (a) GP Access After Hours service, and (b) Patient Streaming Service (call centre).

(3) What funding streams exist for any other (a) services provided by, or (b) operational costs incurred by, GP Access.

* 234  MR BRIGGS: To ask the Minister for Immigration and Citizenship—In respect of the additional capital works, acquisitions, employment and contractual services at schools providing education to children in the Inverbrackie detention centre: what total sum of money (a) has been, and (b) will be, provided to the SA Government to cover associated costs, and what is the itemised breakdown of these costs.

* 235  MR BRIGGS: To ask the Prime Minister—What is the breakdown of costs of all capital works, acquisitions, and contractual services at (a) The Lodge, (b) Kirribilli House, (c) her apartment in Canberra, and (d) her home in Altona, since 23 June 2010.

MR BRIGGS: To ask the Ministers listed below (questions Nos. *236 - *278)— 

(1)  How many personal staff are employed by the Minister.

(2) What is the (a) total cost, and (b) breakdown of costs, of all capital works and acquisitions in the Minister’s private office since 3 December 2007.

* 236  MR BRIGGS: To ask the Prime Minister.

* 237  MR BRIGGS: To ask the Treasurer.

* 238  MR BRIGGS: To ask the Minister representing the Minister for Broadband, Communications and the Digital Economy.

* 239  MR BRIGGS: To ask the Minister for Regional Australia, Regional Development and Local Government.

* 240  MR BRIGGS: To ask the Minister for the Arts.

* 241  MR BRIGGS: To ask the Minister for Foreign Affairs.

* 242  MR BRIGGS: To ask the Minister for Defence.

* 243  MR BRIGGS: To ask the Minister for Immigration and Citizenship.

* 244  MR BRIGGS: To ask the Minister for Infrastructure and Transport.

* 245  MR BRIGGS: To ask the Minister for Health and Ageing.

* 246  MR BRIGGS: To ask the Minister for Families, Housing, Community Services and Indigenous Affairs.

* 247  MR BRIGGS: To ask the Minister for Sustainability, Environment, Water, Population and Communities.

* 248  MR BRIGGS: To ask the Minister representing the Minister for Finance and Deregulation.

* 249  MR BRIGGS: To ask the Minister for School Education, Early Childhood and Youth.

* 250  MR BRIGGS: To ask the Minister representing the Minister for Innovation, Industry, Science and Research.

* 251  MR BRIGGS: To ask the Attorney-General.

* 252  MR BRIGGS: To ask the Minister representing the Minister for Agriculture, Fisheries and Forestry.

* 253  MR BRIGGS: To ask the Minister for Resources and Energy.

* 254  MR BRIGGS: To ask the Minister for Tourism.

* 255  MR BRIGGS: To ask the Minister for Trade.

* 256  MR BRIGGS: To ask the Minister for Climate Change and Energy Efficiency.

* 257  MR BRIGGS: To ask the Minister for Social Inclusion.

* 258  MR BRIGGS: To ask the Minister for Human Services.

* 259  MR BRIGGS: To ask the Minister for Privacy and Freedom of Information.

* 260  MR BRIGGS: To ask the Minister for Home Affairs.

* 261  MR BRIGGS: To ask the Minister for Justice.

* 262  MR BRIGGS: To ask the Minister for Employment Participation and Childcare.

* 263  MR BRIGGS: To ask the Minister for the Status of Women.

* 264  MR BRIGGS: To ask the Minister representing the Minister for Sport.

* 265  MR BRIGGS: To ask the Minister representing the Minister for Indigenous Employment and Economic Development.

* 266  MR BRIGGS: To ask the Minister representing the Minister for Social Housing and Homelessness.

* 267  MR BRIGGS: To ask the Minister representing the Minister for Small Business.

* 268  MR BRIGGS: To ask the Minister for Veterans' Affairs.

* 269  MR BRIGGS: To ask the Minister for Defence Science and Personnel.

* 270  MR BRIGGS: To ask the Minister for Indigenous Health.

* 271  MR BRIGGS: To ask the Assistant Treasurer.

* 272  MR BRIGGS: To ask the Minister for Financial Services and Superannuation.

* 273  MR BRIGGS: To ask the Minister for Mental Health and Ageing.

* 274  MR BRIGGS: To ask the Special Minister of State for the Public Service and Integrity.

* 275  MR BRIGGS: To ask the Special Minister of State.

* 276  MR BRIGGS: To ask the Minister for Defence Materiel.

* 277  MR BRIGGS: To ask the Minister representing the Minister for Jobs and Workplace Relations.

* 278  MR BRIGGS: To ask the Minister representing the Minister for Tertiary Education and Skills.

* 279   MR DUTTON: To ask the Minister for Health and Ageing—In respect of the medicines Duodart, Invega Sustenna, Targin, Symbicort, Botox, Fragmin and Synarel that were recommended for listing on the Pharmaceutical Benefits Scheme by the Pharmaceutical Benefits Advisory Committee, but deferred by the Government: (a) why was the listing of these medicines deferred; (b) what advice was the decision to defer the listing of these medicines based upon; (c) what is the projected cost per annum to the Commonwealth of listing each medicine; (d) what is the saving to the Government over the forward estimates of deferring the listing of these medicines; (e) can she indicate (i) which medicines were considered by Cabinet, and (ii) the estimated length of time of the deferral of the listing of these medicines; and (f) how many people are projected to be prescribed each medicine in the first year of them being listing.

 

 
 
 

B. C. WRIGHT

Clerk of the House of Representatives